Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell wall synthesis proteins in bacteria (chiefly penicillin-binding proteins and associated enzymes such as transglycosylases, transpeptidases, and the Mur family) synthesize and remodel the peptidoglycan layer, which is critical for maintaining cell structure and integrity, resistance to osmotic lysis, and supporting cell division. These proteins are the principal targets of several classes of antibiotics, notably β-lactams and glycopeptides. However, the term "cell wall synthesis proteins" is a non-specific grouping; for drug discovery or biomarker purposes, identification of the particular enzyme (e.g., PBP2, PBP3, MurA) is necessary. The term is too broad for most structured target databases and should be replaced with the specific protein (such as "Penicillin-binding protein 2a (PBP2a)") for actionable and unambiguous use in research and drug development.
Inhibition of transpeptidase/cross-linking activity (β-lactams) Inhibition of transglycosylase (glycopeptides) Blockade of precursor synthesis (fosfomycin, cycloserine)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell wall synthesis proteins.